Genestra Brands TM HMF Cystgen
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 600 mg | Not calculated |
| Lactobacillus acidophilus CUL-60 Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus CUL-60 Source : CUL-60 | 5 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Phosphate de potassium, dibasique, Phosphate de potassium monobasique, Microcrystalline cellulose, Acid citrique, Trehalose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 0.25 sachet | 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides live microorganisms that temporarily modify gut flora. Helps to prevent recurrent urinary tract infections (UTls). An antioxidant for the maintenance of good health. Helps in connective tissue formation and wound healing. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps the body to metabolize fats and proteins. Helps to prevent potassium deficiency (hypokalemia) not resulting from a dietary deficiency. Helps to replenish electrolytes not resulting from a dietary deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 80037490
- Status
- Active licence
- Licence date
- 14 November 2012
- Revision date
- 25 October 2013
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80037490
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Genestra Brands TM HMF Cystgen”, https://compoatlas.com/en/supplements/canada/80037490-genestra-brands-tm-hmf-cystgen, updated 25 October 2013.